Anti–factor Xa activity assays of direct‐acting oral anticoagulants during clinical care: An observational study
Abstract Background Direct‐acting oral anticoagulants (DOACs) are increasingly used to prevent and treat thromboembolism. Although measurement of DOAC concentrations is not currently recommended as part of routine patient care, measurement of DOAC concentrations with anti–factor Xa activity assays h...
Main Authors: | Smrithi Sukumar, Melissa Cabero, Sharon Tiu, Margaret C. Fang, Scott C. Kogan, Janice B. Schwartz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12528 |
Similar Items
-
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator
by: Annika Burger, et al.
Published: (2023-06-01) -
Anticoagulant treatment: the end of the old agents?
by: Lukas Graf, et al.
Published: (2012-09-01) -
Are outpatient anticoagulation management services the wave of the future (again)?
by: Bethany Samuelson Bannow
Published: (2022-05-01) -
Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study
by: Carlos Escobar, et al.
Published: (2024-03-01) -
An update on applications and limitations of direct oral anticoagulants
by: Sharon Wei, et al.
Published: (2023-04-01)